title: Protein kinase CK2 accumulation in "oncophilic" cells: causes and effects.
abstract: At variance with protein kinases expressed by oncogenes, CK2 is endowed with constitutive activity under normal conditions, and no CK2 gain-of-function mutants are known. Its amount, however, is abnormally high in malignant cells where it appears to be implicated in many of the cell biology phenomena associated with cancer. These observations can be reconciled assuming that tumor cells develop an overdue reliance ("non-oncogene addiction") on abnormally high CK2 level. While the potential of this latter to generate an environment favorable to neoplasia is consistent with the global antiapoptotic and prosurvival role played by CK2, it is not clear what is determining accumulation of CK2 in cells "predisposed" to become malignant. Exploiting the apoptosis sensitive (S) or resistant (R) CEM cell model, characterized by sharply different CK2 levels, we have now correlated the level and degradation rate of CK2 to those of the chaperone proteins Hsp90 and Cdc37. We show in particular that persistence of high CK2 level in R-CEM, as opposed to S-CEM, is accompanied by the presence of an immunospecific form of Cdc37 not detectable in S-CEM and refractory to staurosporine-induced degradation.
authors: Department of Biological Chemistry, University of Padova, Viale G. Colombo, 3, 35131 Padova, Italy.
authors: Maria
authors: M
authors: Ruzzene
authors: Kendra
authors: K
authors: Tosoni
authors: Sofia
authors: S
authors: Zanin
authors: Luca
authors: L
authors: Cesaro
authors: Lorenzo A
authors: LA
authors: Pinna
mesh_terms: D047390:Casein Kinase II / Q000378:metabolism*; D006801:Humans; D008954:Models, Biological; D018832:Molecular Chaperones / Q000037:antagonists & inhibitors / Q000378:metabolism; D009369:Neoplasms / Q000201:enzymology*; D010750:Phosphoproteins / Q000378:metabolism; D055550:Protein Stability; D020543:Proteome / Q000378:metabolism
chemical_list: D018832:Molecular Chaperones; D010750:Phosphoproteins; D020543:Proteome; D047390:Casein Kinase II